Prerequisites
The short answer
High-school biology and chemistry. That's it.
Everything else is taught here from scratch — not gestured at, not assumed, not left for a footnote. Amino acids, receptors, half-lives, hazard ratios, trial phases, confidence intervals, the difference between an agonist and an antagonist: all of it is built up in the text, in the order you need it.
This is deliberate, and it is the reason the book is as long as it is. The person who googles "what is BPC-157" deserves a clear, complete, honest answer — not a paywall, not a sales page, and not a paragraph that assumes they already know what a G-protein-coupled receptor is.
What you genuinely need to already have
Cells exist and do things. You know that your body is made of cells, that cells have membranes, and that things happen inside them. That is the depth required.
Molecules are made of atoms, and shape matters. You do not need to draw a benzene ring. You need to accept that a molecule is a specific arrangement of atoms and that changing the arrangement changes what it does.
Comfort with a percentage and a graph. If you can read "15% of the group" and look at a line
going down over time and say "that went down," you have all the mathematics this book requires.
MATH_INTENSITY for this book is formally set to none.
Willingness to sit with uncertainty. This is the real prerequisite, and it is not academic. Large parts of this field are unresolved, and the book says so constantly. If you need every chapter to end with a clean answer, some of them will frustrate you. The chapters that end with "we don't know, and here is precisely what we would need to find out" are doing their job.
What you emphatically do NOT need
| Not required | Why people think they need it |
|---|---|
| Biochemistry | Chapter 1 teaches every bit of molecular biology the book uses, starting from what an amino acid is |
| Pharmacology | Chapters 2 and 4 build receptor theory and drug behavior from nothing |
| Statistics | Chapter 5 teaches p-values, confidence intervals, hazard ratios, and NNT in plain language, with no formulas |
| Organic chemistry | You will never be asked to draw or interpret a structure. Structure is described in words and ASCII |
| A medical background | Clinical context is supplied where it is needed |
| Calculus or algebra | There is none in this book |
| Latin or Greek roots | Terminology is explained on first use, every time |
| Prior reading in this series | The related DataField books deepen the foundations but are not prerequisites |
If you're coming from a specific background
You already work out and read fitness content. You are the reader this book most wants and will most often contradict. You will find that Part I feels slow and Part III is where the argument starts. Resist the temptation to jump to Chapter 17. Chapters 5 and 6 are what make Part III something other than one more confident voice disagreeing with the confident voices you have already read.
You are a clinician. Parts I and II will be partly review — skim them, but read §5.9 on estimands and §5.8 on relative versus absolute risk, because those two sections are what your patients are getting wrong when they quote a number at you. The chapters that will be genuinely new to most clinicians are 15 through 19 (the secretagogue and gray-market landscape your patients are already in) and 34 (what a certificate of analysis actually proves).
You are a student. Read sequentially. The book maps cleanly onto a pharmacology supplement, a biochemistry application module, or a standalone science-of-peptides course, and the instructor companion includes three syllabi at different intensities.
You are here because of one specific molecule. Read Chapter 1, then Chapter 5, then go straight to your molecule's chapter. Then — and this is the part people skip — come back and read Chapter 6. It explains how the information environment you found that molecule in actually works, and it usually recontextualizes everything you read before you got here.
You bought something and want to know if it was a good idea. Chapter 5, then your compound's chapter, then Chapter 19 (if you bought it online) or Chapter 34 (if you want to know what testing could and could not tell you). Chapter 39 if you want to raise it with a physician, which — genuinely — is the single highest-value thing most readers in this position can do.
What this book will ask of you
About 55 hours of reading for the full sequential path, or 12 to 22 hours on one of the focused paths. Chapters run 8,000 to 12,000 words; nobody finishes one in a sitting.
A willingness to be wrong about something you were confident about. Almost every reader arrives believing at least one thing this book will contradict — in either direction. Some readers arrive convinced peptides are miracle compounds; some arrive convinced they are all snake oil. Both groups will find chapters that annoy them, and both groups' annoyance is the book working.
Twelve fields per peptide, if you do the project. The Peptide Evidence Dossier (Appendix C) is optional in the sense that you can read the book without it, and essential in the sense that it is the only part you will still be using in five years.
A note on what "science education" means here
This book will not make you qualified to advise anyone medically, including yourself. No book can do that, and any book that implies otherwise should be closed.
What it can do — and what it is built to do — is make you literate: able to read a claim, locate the evidence behind it, judge the quality of that evidence, and know precisely what you still don't know. That is a real skill, it is rarer than it should be, and it is the difference between having an opinion about a peptide and having a position on one.
It is also, usefully, portable. The reader who can properly evaluate a claim about BPC-157 can evaluate a claim about a supplement, a diet, a device, a therapy, or a headline. The peptides are the curriculum. The judgment is the point.